In human obesity, increased oxidant stress is an important factor in the development of atherosclerosis. 1 Oxidation of the lipid components of low-density lipoprotein (LDL) is causative, because oxidized LDL contributes to many of the stages of progression of atherosclerosis. In particular, small dense LDL particle, which is frequently associated with abdominal obesity, 2 is susceptible to oxidative modulation. Even in obese children, oxidative stress including oxidized LDL formation is increased. 3, 4 Platelet activating factor acetylhydrolase (PAF-AH) is a Ca 2ϩ -independent phospholipase A 2 that catalyzes the conversion of platelet activating factor (PAF) to lyso-PAF. Another physiological function of plasma PAF-AH is to degrade oxidized phospholipids, which are formed during the oxidative modification of lipoproteins. Therefore, PAF-AH may play a significant role in atherogenesis as an antioxidant. We measured PAF-AH concentration in children with abdominal obesity and investigated its relationship with anthropometric and metabolic parameters.
ence is a major component of metabolic syndrome. In children, however, waist/height ratio rather than waist circumference is a better predictor of cardiovascular risk, because their height increases with aging. 10 Therefore, our results demonstrated that PAF-AH concentration, as well as a high LDLC level, is associated with abdominal adiposity in obese children.
Tsimihodimos et al reported that LDL-associated PAF-AH activity is mainly distributed on the small dense LDL particles. 11 In our study, however, PAF-AH concentration is not correlated with peak LDL particle diameter. In children with abdominal obesity, antioxidant modulation of lipoproteins may precede the development of the predominance of small dense LDL. In Japanese adults with hyperlipidemia, the distribution of PAF-AH between HDL and LDL was altered with higher concentration of HDL-associated PAF-AH and lower non-HDL associated PAF-AH to apoB ratio. 6 In our study, PAF-AH to apoB ratio correlated negatively with HDLC level (r 2 ϭ0.244, Pϭ0.0437), not with LDLC level or peak LDL particle diameter. Therefore, not only plasma concentration of PAF-AH but also the distribution of PAF-AH should be investigated to determine the mechanisms contributing to atherogenicity in obese children.
Plasma PAF-AH deficiency is associated with atherosclerotic occlusive disease in Japanese adults, suggesting a protective role of PAF-AH. 12 In abdominal obese children, PAF-AH concentration was elevated with increasing degree of abdominal fatness. PAF-AH may play an important role as the antioxidative factor even in the early phase of atherosclerosis. 
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